Insight Biopharmaceuticals Ltd.
Records under this name other than patents Insight Biopharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Insight Biopharmaceuticals Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,893,240 | High level expression of recombinant human erythropoietin having a modified 5′-UTR Lapsed on the fee record Ended Feb 22, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 22, 2019 | USPTO record |
| US 7,795,255 | Rigidified compounds for modulating heparanase activity Lapsed on the fee record Ended Sep 14, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 14, 2018 | USPTO record |
| US 6,190,875 | Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe Term ended Term ended Jul 10, 2018 · USPTO record | Term ended | Term ended Jul 10, 2018 | USPTO record |
| US 6,177,545 | Heparanase specific molecular probes and their use in research and medical applications Term ended Term ended May 1, 2018 · USPTO record | Term ended | Term ended May 1, 2018 | USPTO record |
| US 7,666,651 | Polypeptide having heparanase activity Lapsed on the fee record Ended Feb 23, 2018 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2018 | USPTO record |
| US 6,348,344 | Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |
| US 6,426,209 | Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same Term ended Term ended Sep 2, 2017 · USPTO record | Term ended | Term ended Sep 2, 2017 | USPTO record |
| US 6,531,129 | Heparanase specific molecular probes and their use in research and medical applications Term ended Term ended Sep 2, 2017 · USPTO record | Term ended | Term ended Sep 2, 2017 | USPTO record |
| US 6,699,672 | Heparanase specific molecular probes and their use research and medical applications Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |
| US 6,946,131 | Heparanase activity neutralizing anti-heparanase monoclonal antibody Term ended Ended no later than Sep 2, 2017 · USPTO record | Term ended | Ended no later than Sep 2, 2017 | USPTO record |